Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Calpain-5 Gene Expression in the Mouse Eye and Brain
Schaefer et al. BMC Res Notes (2017) 10:602 DOI 10.1186/s13104-017-2927-8 BMC Research Notes RESEARCH NOTE Open Access Calpain‑5 gene expression in the mouse eye and brain Kellie Schaefer1, MaryAnn Mahajan1, Anuradha Gore1, Stephen H. Tsang3, Alexander G. Bassuk4 and Vinit B. Mahajan1,2* Abstract Objective: Our objective was to characterize CAPN5 gene expression in the mouse central nervous system. Mouse brain and eye sections were probed with two high-afnity RNA oligonucleotide analogs designed to bind CAPN5 RNA and one scramble, control oligonucleotide. Images were captured in brightfeld. Results: CAPN5 RNA probes were validated on mouse breast cancer tumor tissue. In the eye, CAPN5 was expressed in the ganglion cell, inner nuclear and outer nuclear layers of the retina. Signal could not be detected in the ciliary body or the iris because of the high density of melanin. In the brain, CAPN5 was expressed in the granule cell layers of the hippocampus and cerebellum. There was scattered expression in pons. The visual cortex showed faint signal. Most signal in the brain was in a punctate pattern. Keywords: CAPN5, Calpain, In situ hybridization, Retina, Brain, Gene expression Introduction pigmentosa, retinal neovascularization, and proliferative Calpain-5 (CAPN5) is a member of the calpain family of retinopathy. Which ultimately leads to blindness [20]. calcium-activated proteases that target a variety of path- Currently there is no treatment. ways to exert control over numerous processes, includ- An important question to understanding how CAPN5 ing tissue necrosis, cytoskeletal remodeling, cell-cycle leads to disease is identifying which tissues CAPN5 is control, cell migration, myofbril turnover, regulation expressed in and the levels of CAPN5 in those tissues. -
Reconstructability Analysis As a Tool for Identifying Gene-Gene Interactions in Studies of Human Diseases
Portland State University PDXScholar Systems Science Faculty Publications and Presentations Systems Science 3-2010 Reconstructability Analysis As A Tool For Identifying Gene-Gene Interactions In Studies Of Human Diseases Stephen Shervais Eastern Washington University Patricia L. Kramer Oregon Health & Science University Shawn K. Westaway Oregon Health & Science University Nancy J. Cox University of Chicago Martin Zwick Portland State University, [email protected] Follow this and additional works at: https://pdxscholar.library.pdx.edu/sysc_fac Part of the Bioinformatics Commons, Diseases Commons, and the Genomics Commons Let us know how access to this document benefits ou.y Citation Details Shervais, S., Kramer, P. L., Westaway, S. K., Cox, N. J., & Zwick, M. (2010). Reconstructability Analysis as a Tool for Identifying Gene-Gene Interactions in Studies of Human Diseases. Statistical Applications In Genetics & Molecular Biology, 9(1), 1-25. This Article is brought to you for free and open access. It has been accepted for inclusion in Systems Science Faculty Publications and Presentations by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: [email protected]. Statistical Applications in Genetics and Molecular Biology Volume 9, Issue 1 2010 Article 18 Reconstructability Analysis as a Tool for Identifying Gene-Gene Interactions in Studies of Human Diseases Stephen Shervais∗ Patricia L. Kramery Shawn K. Westawayz Nancy J. Cox∗∗ Martin Zwickyy ∗Eastern Washington University, [email protected] yOregon Health & Science University, [email protected] zOregon Health & Science University, [email protected] ∗∗University of Chicago, [email protected] yyPortland State University, [email protected] Copyright c 2010 The Berkeley Electronic Press. -
Calpain-10 Regulates Actin Dynamics by Proteolysis of Microtubule-Associated Protein 1B
www.nature.com/scientificreports OPEN Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B Received: 15 September 2015 Tomohisa Hatta1, Shun-ichiro Iemura1,6, Tomokazu Ohishi2, Hiroshi Nakayama3, Accepted: 1 November 2018 Hiroyuki Seimiya 2, Takao Yasuda4, Katsumi Iizuka5, Mitsunori Fukuda4, Jun Takeda5, Published: xx xx xxxx Tohru Natsume1 & Yukio Horikawa5 Calpain-10 (CAPN10) is the calpain family protease identifed as the frst candidate susceptibility gene for type 2 diabetes mellitus (T2DM). However, the detailed molecular mechanism has not yet been elucidated. Here we report that CAPN10 processes microtubule associated protein 1 (MAP1) family proteins into heavy and light chains and regulates their binding activities to microtubules and actin flaments. Immunofuorescent analysis of Capn10−/− mouse embryonic fbroblasts shows that MAP1B, a member of the MAP1 family of proteins, is localized at actin flaments rather than at microtubules. Furthermore, fuorescence recovery after photo-bleaching analysis shows that calpain-10 regulates actin dynamics via MAP1B cleavage. Moreover, in pancreatic islets from CAPN10 knockout mice, insulin secretion was signifcantly increased both at the high and low glucose levels. These fndings indicate that defciency of calpain-10 expression may afect insulin secretion by abnormal actin reorganization, coordination and dynamics through MAP1 family processing. Calpains are a family of intracellular non-lysosomal calcium-activated neutral cysteine proteases known to cleave various substrate proteins and modulate their activities. Tere are 16 calpains, some of which are ubiquitously expressed and others displaying tissue-specifc distribution. Some calpains contain a penta-EF-hand domain (typical or classical calpains), and others do not (atypical calpains). Several calpain family members are impli- cated in the development of various diseases including Alzheimer’s disease, cataracts, ischemic stroke, traumatic brain injury, limb-girdle muscular dystrophy 2A and type 2 diabetes mellitus (T2DM)1. -
107Th ENMC International Workshop: the Management of Cardiac Involvement in Muscular Dystrophy and Myotonic Dystrophy
Neuromuscular Disorders 13 (2003) 166–172 www.elsevier.com/locate/nmd Workshop report 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands K. Bushby*, F. Muntoni, J.P. Bourke Department of Neuromuscular Genetics, Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK Received 1 August 2002; accepted 16 August 2002 1. Introduction symptomatic presentation [13,14]. Although evidence in these rare conditions of the effect of treatment is lacking Sixteen participants from Austria, France, Germany, [15], extrapolation from other conditions causing heart fail- Italy, the Netherlands and the UK met to discuss the cardiac ure with dilated cardiomyopathy means that there is a strong implications of the diagnosis of muscular dystrophy and case for the use of ACE inhibitors and potentially also beta myotonic dystrophy. The group included both myologists blockers, certainly in the presence of detectable abnormal- and cardiologists from nine different European centers. The ities and possibly preventatively [16–25]. aims of the workshop were to agree and report minimum The recommendations of the group are as follows. recommendations for the investigation and treatment of cardiac involvement in muscular and myotonic dystrophies, 2.1. DMD and define areas where further research is needed. During the workshop, all participants contributed to a review and † Patients should have a cardiac investigation (echo and assessment of the published evidence in each area and electrocardiogram (ECG)) at diagnosis. current practice amongst the group. Consensus statements † DMD patients should have cardiac investigations before for the management of dystrophinopathy, myotonic dystro- any surgery, every 2 years to age 10 and annually after phy, limb-girdle muscular dystrophy, Emery Dreifuss age 10. -
Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients
Original Endocrinol Metab 2018;33:364-371 https://doi.org/10.3803/EnM.2018.33.3.364 Article pISSN 2093-596X · eISSN 2093-5978 Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients Ji Sun Nam1,2, Jung Woo Han1, Sang Bae Lee1, Ji Hong You1, Min Jin Kim1, Shinae Kang1,2, Jong Suk Park1,2, Chul Woo Ahn1,2 1Department of Internal Medicine, 2Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea Background: Genetic variations in calpain-10 and adiponectin gene are known to influence insulin secretion and resistance in type 2 diabetes mellitus. Recently, several single nucleotide polymorphisms (SNPs) in calpain-10 and adiponectin gene have been report- ed to be associated with type 2 diabetes and various metabolic derangements. We investigated the associations between specific cal- pain-10 and adiponectin gene polymorphisms and Korean type 2 diabetes patients. Methods: Overall, 249 type 2 diabetes patients and 131 non-diabetic control subjects were enrolled in this study. All the subjects were genotyped for SNP-43 and -63 of calpain-10 gene and G276T and T45G frequencies of the adiponectin gene. The clinical char- acteristics and measure of glucose metabolism were compared within these genotypes. Results: Among calpain-10 polymorphisms, SNP-63 T/T were more frequent in diabetes patients, and single SNP-63 increases the susceptibility to type 2 diabetes. However, SNP-43 in calpain-10 and T45G and intron G276T in adiponectin gene were not signifi- cantly associated with diabetes, insulin resistance, nor insulin secretion. Conclusion: Variations in calpain-10, SNP-63 seems to increase the susceptibility to type 2 diabetes in Koreans while SNP-43 and adiponectin SNP-45, -276 are not associated with impaired glucose metabolism. -
In a Three-Dimensional Reconstructed Human Epidermis Filaggrin-2 Is Essential for Proper Cornification
Citation: Cell Death and Disease (2015) 6, e1656; doi:10.1038/cddis.2015.29 OPEN & 2015 Macmillan Publishers Limited All rights reserved 2041-4889/15 www.nature.com/cddis In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification V Pendaries1,2,3, M Le Lamer1,2,3, L Cau1,2,3, B Hansmann4, J Malaisse5, S Kezic6, G Serre1,2,3 and M Simon*,1,2,3 Atopic dermatitis is a chronic inflammatory skin disease with defects in the epidermal barrier. In a cohort of African-American children, a FLG2 nonsense mutation has been associated with the disease. In the epidermis of European patients, the expression of filaggrin-2, the filaggrin-related protein encoded by FLG2, is decreased. To describe the function of filaggrin-2 and evaluate the impact of its deficiency, its expression was downregulated using lentivirus-mediated shRNA interference in a three-dimensional reconstructed human epidermis (RHE) model. This resulted in parakeratosis and a compact stratum corneum, presence of abnormal vesicles inside the corneocytes, increased pH and reduced amounts of free amino acids at the RHE surface, leading to increased sensitivity to UVB radiations. The expression of differentiation markers was slightly modified. However, we observed reduced proteolytic processing of corneodesmosin, hornerin and filaggrin in parallel with reduced amounts of caspase-14 and bleomycin hydrolase. Our data demonstrated that filaggrin-2 is important for a proper cornification and a functional stratum corneum. Its downregulation in atopic patients may be involved in the disease-associated epidermis impairment. Cell Death and Disease (2015) 6, e1656; doi:10.1038/cddis.2015.29; published online 19 February 2015 Atopic dermatitis (AD; OMIM #603165), also known as atopic homologous repeats and a S100-homologous N-terminal eczema, is a very common inflammatory skin disease.1,2 It is domain. -
Μ-CALPAIN GENE KNOCKDOWN of MUSCLE SATELLITE CELLS USING PSILENCER VECTOR Muthuraman Pandurangan, Hoa V
µ-CALPAIN GENE KNOCKDOWN OF MUSCLE SATELLITE CELLS USING PSILENCER VECTOR Muthuraman Pandurangan, Hoa V. Ba, Dawoon Jeong, Beom-Young Park1, Soo-Hyun Cho1, Inho Hwang* Department of Animal Science and Institute of Rare Earth for Biological Aplication, Chonbuk National University, Jeonju, 561- 756, Korea 1Quality control and utilization of animal products division, National Institute of Animal Science, Suwon 441-706, South Korea Abstract – This study was designed to find the key called μ- and m-) which are the best-characterized role of μ-calpain and caspases using RNA calpains and calpain 3 (also called p94) which is interference mediated silencing of μ-calpain and highly expressed in this tissue. However, since caspase 9 during satellite cell proliferation. For this conventional inhibitors used for the studies of the experiment, four separate siRNA sequences were functions of these enzymes lack specificity, the screened for their ability to inhibit μ-calpain gene expression. Following optimizing the transfection individual physiological function and biochemical conditions for cell number, volume of transfection mechanism of these three isoforms, especially μ- agent used and the appropriate concentration of calpain, are not clear (3). In contrast, RNA each siRNA, quantitative real-time PCR were used interference (RNAi) has a great potential to to assess the level of inhibition of gene expression distinguish the functions of each member in a achieved by all siRNA sequences used. CAPN1, closely related gene family or to selectively target caspase 3, caspase 7, caspase 9, Hsp27, Hsp70 and a mutant gene, especially to study the functions of Hsp90 mRNA expression were quantified in a particular isoform. -
The Limb-Girdle Muscular Dystrophies and the Dystrophinopathies Review Article
Review Article 04/25/2018 on mAXWo3ZnzwrcFjDdvMDuzVysskaX4mZb8eYMgWVSPGPJOZ9l+mqFwgfuplwVY+jMyQlPQmIFeWtrhxj7jpeO+505hdQh14PDzV4LwkY42MCrzQCKIlw0d1O4YvrWMUvvHuYO4RRbviuuWR5DqyTbTk/icsrdbT0HfRYk7+ZAGvALtKGnuDXDohHaxFFu/7KNo26hIfzU/+BCy16w7w1bDw== by https://journals.lww.com/continuum from Downloaded Downloaded from Address correspondence to https://journals.lww.com/continuum Dr Stanley Jones P. Iyadurai, Ohio State University, Wexner The Limb-Girdle Medical Center, Department of Neurology, 395 W 12th Ave, Columbus, OH 43210, Muscular Dystrophies and [email protected]. Relationship Disclosure: by mAXWo3ZnzwrcFjDdvMDuzVysskaX4mZb8eYMgWVSPGPJOZ9l+mqFwgfuplwVY+jMyQlPQmIFeWtrhxj7jpeO+505hdQh14PDzV4LwkY42MCrzQCKIlw0d1O4YvrWMUvvHuYO4RRbviuuWR5DqyTbTk/icsrdbT0HfRYk7+ZAGvALtKGnuDXDohHaxFFu/7KNo26hIfzU/+BCy16w7w1bDw== Dr Iyadurai has received the Dystrophinopathies personal compensation for serving on the advisory boards of Allergan; Alnylam Stanley Jones P. Iyadurai, MSc, PhD, MD; John T. Kissel, MD, FAAN Pharmaceuticals, Inc; CSL Behring; and Pfizer, Inc. Dr Kissel has received personal ABSTRACT compensation for serving on a consulting board of AveXis, Purpose of Review: The classic approach to identifying and accurately diagnosing limb- Inc; as journal editor of Muscle girdle muscular dystrophies (LGMDs) relied heavily on phenotypic characterization and & Nerve; and as a consultant ancillary studies including muscle biopsy. Because of rapid advances in genetic sequencing for Novartis AG. Dr Kissel has received research/grant methodologies, -
Splicing Impact of Deep Exonic Missense Variants in CAPN3 Explored Systematically by Minigene Functional Assay
bioRxiv preprint doi: https://doi.org/10.1101/2020.03.26.009332; this version posted March 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Splicing impact of deep exonic missense variants in CAPN3 explored systematically by minigene functional assay Eugénie Dionnet*1, Aurélia Defour*1, Nathalie Da Silva1, Alexandra Salvi1, Nicolas Lévy1,2, Martin Krahn1,2, Marc Bartoli1, Francesca Puppo#1 and Svetlana Gorokhova#1,2 1 Aix Marseille Univ, INSERM, MMG, U 1251, Marseille, France. 2 Service de génétique Médicale, Hôpital de la Timone, APHM, Marseille, France * both authors should be considered as co-first authors # both authors should be considered as co-last authors Corresponding authors: Francesca Puppo and Svetlana Gorokhova Corresponding authors’ postal address: Marseille Medical Genetics, U 1251, Aix Marseille Université, Faculté des Sciences Médicales et Paramédicales, 27 bd Jean Moulin 13385 Marseille, France. Corresponding authors’ phone: +33 4 91 32 49 06, fax +33 4 91 80 43 19 Corresponding authors’ e-mail addresses: [email protected], [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.26.009332; this version posted March 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. -
Influenza Virus Infection Modulates the Death Receptor Pathway During Early Stages of Infection in Human Bronchial Epithelial Cells
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Physiol Manuscript Author Genomics. Author Manuscript Author manuscript; available in PMC 2019 September 01. Published in final edited form as: Physiol Genomics. 2018 September 01; 50(9): 770–779. doi:10.1152/physiolgenomics.00051.2018. Influenza virus infection modulates the death receptor pathway during early stages of infection in human bronchial epithelial cells Sreekumar Othumpangat, Donald H. Beezhold, and John D. Noti Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia Abstract Host-viral interaction occurring throughout the infection process between the influenza A virus (IAV) and bronchial cells determines the success of infection. Our previous studies showed that the apoptotic pathway triggered by the host cells was repressed by IAV facilitating prolonged survival of infected cells. A detailed understanding on the role of IAV in altering the cell death pathway during early-stage infection of human bronchial epithelial cells (HBEpCs) is still unclear. We investigated the gene expression profiles of IAV-infected vs. mock-infected cells at the early stage of infection with a PCR array for death receptor (DR) pathway. At early stages infection (2 h) with IAV significantly upregulated DR pathway genes in HBEpCs, whereas 6 h exposure to IAV resulted in down-regulation of the same genes. IAV replication in HBEpCs decreased the levels of DR pathway genes including TNF-receptor superfamily 1, Fas-associated death domain, caspase-8, and caspase-3 by 6 h, resulting in increased survival of cells. -
Clinical Variability in Calpainopathy: What Makes the Difference?
European Journal of Human Genetics (2002) 10, 825 – 832 ª 2002 Nature Publishing Group All rights reserved 1018 – 4813/02 $25.00 www.nature.com/ejhg ARTICLE Clinical variability in calpainopathy: What makes the difference? Fla´via de Paula1, Mariz Vainzof1, Maria Rita Passos-Bueno1, Rita de Ca´ssia M Pavanello1, Sergio Russo Matioli1, Louise VB Anderson3, Vincenzo Nigro2 and Mayana Zatz*,1 1Human Genome Research Center-Departamento de Biologia, IB Universidade de Sa˜o Paulo, Brazil; 2TIGEM and Dipartimento di Patologia Generale, Seconda Universita’degli studi di Napoli, Italy; 3Neurobiology Department, University Medical School, Framlington Place, Newcastle upon Tyne, UK Limb girdle muscular dystrophies (LGMD) are a heterogeneous group of genetic disorders characterised by progressive weakness of the pelvic and shoulder girdle muscles and a great variability in clinical course. LGMD2A, the most prevalent form of LGMD, is caused by mutations in the calpain-3 gene (CAPN- 3). More than 100 pathogenic mutations have been identified to date, however few genotype : phenotype correlation studies, including both DNA and protein analysis, have been reported. In this study we screened 26 unrelated LGMD2A Brazilian families (75 patients) through Single-Stranded Conformation Polymorphism (SSCP), Denaturing high-performance liquid chromatography (DHPLC) and sequencing of abnormal fragments which allowed the identification of 47 mutated alleles (approximately 90%). We identified two recurrent mutations (R110X and 2362-2363AG4TCATCT) and seven novel pathogenic mutations. Interestingly, 41 of the identified mutations (approximately 80%) were concentrated in only 6 exons (1, 2, 4, 5, 11 and 22), which has important implications for diagnostic purposes. Protein analysis, performed in 28 patients from 25 unrelated families showed that with exception of one patient (with normal/slight borderline reduction of calpain) all others had total or partial calpain deficiency. -
Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma
G C A T T A C G G C A T genes Article Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma Dumitru A. Iacobas Personalized Genomics Laboratory, CRI Center for Computational Systems Biology, Roy G Perry College of Engineering, Prairie View A&M University, Prairie View, TX 77446, USA; [email protected]; Tel.: +1-936-261-9926 Received: 1 August 2020; Accepted: 1 September 2020; Published: 2 September 2020 Abstract: Publicly available (own) transcriptomic data have been analyzed to quantify the alteration in functional pathways in thyroid cancer, establish the gene hierarchy, identify potential gene targets and predict the effects of their manipulation. The expression data have been generated by profiling one case of papillary thyroid carcinoma (PTC) and genetically manipulated BCPAP (papillary) and 8505C (anaplastic) human thyroid cancer cell lines. The study used the genomic fabric paradigm that considers the transcriptome as a multi-dimensional mathematical object based on the three independent characteristics that can be derived for each gene from the expression data. We found remarkable remodeling of the thyroid hormone synthesis, cell cycle, oxidative phosphorylation and apoptosis pathways. Serine peptidase inhibitor, Kunitz type, 2 (SPINT2) was identified as the Gene Master Regulator of the investigated PTC. The substantial increase in the expression synergism of SPINT2 with apoptosis genes in the cancer nodule with respect to the surrounding normal tissue (NOR) suggests that SPINT2 experimental overexpression may force the PTC cells into apoptosis with a negligible effect on the NOR cells. The predictive value of the expression coordination for the expression regulation was validated with data from 8505C and BCPAP cell lines before and after lentiviral transfection with DDX19B.